Johnson & Johnson MedTech (NYSE: JNJ) announced that it received CE mark approval for its dual-energy ThermoCool SmartTouch ...

Johnson & Johnson MedTech, a global leader in cardiac arrhythmia treatment, today announced European CE mark approval of the Dual Energy THERMOCOOL SMARTTOUCH™ SF Catheter for the treatment of cardiac ...

Johnson & Johnson stock (NYSE: JNJ) lost about 7% in 2024, underperforming the broader S&P 500 index, which gained 23% for ...

Johnson & Johnson pauses U.S. Varipulse cases to investigate neurovascular events. The FDA-approved device integrates PFA ...

The temporary pause follows reports of four cases of neurovascular events in the US external evaluation study.

Mendaera announced today that it appointed surgical robotics veteran Eric Davidson as its first chief commercial officer (CCO ...

Onera Health, a leader in transforming sleep diagnostics and monitoring, is excited to announce the appointment of Maria ...

India's medical device industry, valued at US$12 billion, has become a growing hub for innovation, attracting venture capital ...

The FDA and European Medicines Agency (EMA) have granted several key designations to nipocalimab including: U.S. FDA Fast Track designation in hemolytic disease of the fetus and newborn (HDFN) and ...

Johnson & Johnson halted the limited rollout of its Varipulse pulsed field ablation system on Jan. 5 to “investigate the root causes of four reported neurovascular events in the U.S. external ...

Med Tech & Diagnostics Analysts Matson and Saxon, along with Dr. Kevin Cronin, Assistant Professor of Orthopaedic Surgery at the University ...

FDA grants priority review tag to JNJ's nipocalimab BLA for gMG and asks for new warnings on GSK & PFE's RSV vaccine labels.